Anbio Biotechnology

Last updated September 27, 2026

Organization details

Legal name
Anbio Biotechnology
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2835 — In Vitro & In Vivo Diagnostic Substances
Jurisdiction of incorporation
Cayman Islands
Headquarters city
Frankfurt AM Main
Headquarters country
Germany
Fiscal year end
December
Ticker symbol
NNNN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001982708

Board of directors

Organizations in the same sector, closest in location and size first.

Questions about Anbio Biotechnology

How many directors are on Anbio Biotechnology's board?

Anbio Biotechnology's board has 4 directors: Cany Xu, David H. Hsu, Michael W.c Zhang and Nancy Hartzler.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="anbio-biotechnology"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.